• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指南符合性银屑病护理的障碍:分析与概念。

Barriers to guideline-compliant psoriasis care: analyses and concepts.

机构信息

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2016 Apr;30(4):569-75. doi: 10.1111/jdv.13452. Epub 2015 Nov 4.

DOI:10.1111/jdv.13452
PMID:26538533
Abstract

Despite the availability of effective therapeutics and evidence-based treatment guidelines, a substantial proportion of patients with moderate-to-severe psoriasis does not receive appropriate care. This under-provision of health care may cause further worsening of health, remarkable limitations of the patient's quality of life, and indirect costs for the health care system. In order to provide guideline-compliant care for every psoriasis patient, it is important to identify barriers obstructing optimal care. Studies have identified various barriers on the physician's and on the patient's side; however, respective studies approached only single barriers, and not all of them in the context of psoriasis. Other publications that describe barriers systematically did not focus on psoriasis either. The objective of this literature review was to identify barriers and facilitators, based on studies analysing quality of care and single barriers, resulting in a comprehensive model of causal factors. Our analyses revealed three categories of barriers - patient-related, physician-related and external factors: On the patient side, we found non-adherence to therapies to be an important barrier, often in close association with psychiatric factors. Barriers on the physician's side predominantly are incomplete knowledge of the guidelines as well as the complexity of psoriasis comorbidity. In some countries, payment for patients with complex disease status is poor and inconsistent reimbursement regulations potentially interfere with optimal care. The current analysis indicates that most barriers are interdependent. Thus, measures approaching related barriers simultaneously are required. To improve care for psoriasis patients, further studies systematically addressing all potentially relevant barriers in conjoint are needed.

摘要

尽管有有效的治疗方法和基于证据的治疗指南,但相当一部分中重度银屑病患者得不到适当的护理。这种医疗服务的不足可能会导致健康状况进一步恶化,患者生活质量显著受限,并给医疗保健系统带来间接成本。为了为每一位银屑病患者提供符合指南的护理,重要的是要确定阻碍最佳护理的障碍。研究已经确定了医生和患者方面的各种障碍;然而,各自的研究只涉及单一障碍,而不是所有障碍都与银屑病有关。其他系统描述障碍的出版物也没有关注银屑病。本文献综述的目的是根据分析护理质量和单一障碍的研究,确定障碍和促进因素,从而建立一个因果因素的综合模型。我们的分析揭示了三类障碍 - 患者相关、医生相关和外部因素:在患者方面,我们发现不遵守治疗方案是一个重要的障碍,通常与精神因素密切相关。医生方面的障碍主要是对指南的不完全了解以及银屑病合并症的复杂性。在一些国家,对病情复杂的患者的付费情况较差,而不一致的报销规定可能会干扰最佳护理。目前的分析表明,大多数障碍是相互依存的。因此,需要同时采取措施来解决相关的障碍。为了改善银屑病患者的护理,需要进一步研究系统地解决所有潜在的相关障碍。

相似文献

1
Barriers to guideline-compliant psoriasis care: analyses and concepts.指南符合性银屑病护理的障碍:分析与概念。
J Eur Acad Dermatol Venereol. 2016 Apr;30(4):569-75. doi: 10.1111/jdv.13452. Epub 2015 Nov 4.
2
Guideline-compliant prescription of biologicals and possible barriers in dermatological practices in Bavaria.巴伐利亚州皮肤科实践中符合指南的生物制剂处方和可能存在的障碍。
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):978-984. doi: 10.1111/jdv.14811. Epub 2018 Feb 7.
3
Barriers and suggestions for improving the implementation of guidelines in the systemic treatment of moderate to severe psoriasis: A literature review.改善中重度银屑病系统治疗指南实施的障碍和建议:文献回顾。
Ann Dermatol Venereol. 2024 Jun;151(2):103280. doi: 10.1016/j.annder.2024.103280. Epub 2024 May 22.
4
Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators.银屑病护理质量及指南依从性治疗的评估。一种新的质量指标体系的建立。
Dermatology. 2009;219(1):54-8. doi: 10.1159/000218161. Epub 2009 May 7.
5
[Individual and collective facilitators of and barriers to the use of clinical practice guidelines by physicians: a literature review].[医生使用临床实践指南的个体和集体促进因素及障碍:文献综述]
Rev Epidemiol Sante Publique. 2003 Feb;51(1 Pt 1):65-80.
6
Three years after the publication of the German (S3) evidence based psoriasis guidelines--was it worth the effort?德国(S3)循证银屑病指南发布三年后——这是否值得付出努力?
J Dtsch Dermatol Ges. 2009 Dec;7(12):1044-7. doi: 10.1111/j.1610-0387.2009.07275.x.
7
Barriers to physician adherence to a subfertility guideline.医生遵循不孕症指南的障碍。
Hum Reprod. 2005 Dec;20(12):3301-6. doi: 10.1093/humrep/dei220. Epub 2005 Jul 29.
8
Management of psoriasis and its comorbidities in primary care.基层医疗中银屑病及其合并症的管理。
Br J Nurs. 2011;20(18):1186, 1188-90, 1192. doi: 10.12968/bjon.2011.20.18.1186.
9
Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?哪些医生和实践特征与遵循抑郁和焦虑障碍的循证指南有关?
Med Care. 2010 Mar;48(3):240-8. doi: 10.1097/MLR.0b013e3181ca27f6.
10
Perceived barriers to and facilitators of the implementation of priority clinical preventive services guidelines.实施优先临床预防服务指南的感知障碍与促进因素
Am J Manag Care. 2007 Mar;13(3):150-5.

引用本文的文献

1
Drug Insurance and Psoriasis Severity: A Retrospective Cohort Study.药物保险与银屑病严重程度:一项回顾性队列研究
J Health Econ Outcomes Res. 2025 Feb 7;12(1):51-57. doi: 10.36469/001c.127820. eCollection 2025.
2
Value of PASI90 Versus Merit-Based Incentive Payment System Efficacy Measures.银屑病面积和严重程度指数改善90%(PASI90)与基于绩效的激励支付系统疗效指标的价值。
J Psoriasis Psoriatic Arthritis. 2022 Jul;7(3):140-149. doi: 10.1177/24755303221082623. Epub 2022 Apr 19.
3
Psoriasis care in Germany: do patients who receive better care travel longer?
德国的银屑病护理:获得更好护理的患者就医路程会更远吗?
Res Health Serv Reg. 2022 Aug 30;1(1):8. doi: 10.1007/s43999-022-00008-0.
4
"I Was Almost in Disbelief" - Qualitative Analysis of Experiences and Expectations Among Psoriasis Patients Undergoing Biologic Treatment with Secukinumab.“我几乎不敢相信”——司库奇尤单抗生物治疗银屑病患者的经历与期望的定性分析
Patient Prefer Adherence. 2024 Jun 24;18:1299-1310. doi: 10.2147/PPA.S458643. eCollection 2024.
5
Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review.甲氨蝶呤与其他口服改善病情抗风湿药联合治疗银屑病:一项系统评价
Dermatol Ther (Heidelb). 2023 Apr;13(4):891-909. doi: 10.1007/s13555-023-00903-5. Epub 2023 Mar 21.
6
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative.提升银屑病患者的护理标准:泛欧洲多方利益相关者倡议Epicensus的“行动呼吁”
Dermatol Ther (Heidelb). 2023 Jan;13(1):245-268. doi: 10.1007/s13555-022-00846-3. Epub 2022 Dec 9.
7
Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists.中度斑块状银屑病治疗中的差距:沙特皮肤科医生的一项调查。
J Family Med Prim Care. 2021 Dec;10(12):4519-4524. doi: 10.4103/jfmpc.jfmpc_1207_21. Epub 2021 Dec 27.
8
[Regional variations in healthcare for patients with psoriasis and atopic dermatitis in Germany].[德国银屑病和特应性皮炎患者医疗保健的地区差异]
Hautarzt. 2022 Jan;73(1):27-39. doi: 10.1007/s00105-021-04913-2. Epub 2021 Nov 25.
9
Prescription Behaviour and Barriers to Prescription of Biologicals for Treatment of Chronic Inflammatory Skin Diseases in Dermatological Practice in Two German Federal States.德国两个联邦州皮肤科实践中治疗慢性炎症性皮肤病的生物制剂处方行为和处方障碍。
Acta Derm Venereol. 2021 Sep 28;101(9):adv00560. doi: 10.2340/00015555-3901.
10
Alcohol in Psoriasis-From Bench to Bedside.银屑病与饮酒:从基础到临床。
Int J Mol Sci. 2021 May 7;22(9):4987. doi: 10.3390/ijms22094987.